274.47 0.00 (0.00%)
After hours: 4:36PM EDT
|Bid||274.41 x 1100|
|Ask||274.50 x 800|
|Day's Range||274.01 - 283.26|
|52 Week Range||177.93 - 398.88|
|Beta (3Y Monthly)||2.37|
|PE Ratio (TTM)||59.13|
|Earnings Date||Jul 24, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||340.19|
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Since Align Technology, Inc. (NASDAQ:ALGN) released its earnings in March 2019, the consensus outlook from analysts...
While many investors are focused on the negative impacts of tariffs and the U.S.-China trade war on corporate profits, they may be overlooking another sizable threat, which is rapidly rising labor costs. The median company in the S&P 500 Index (SPX) pays out 13% of its revenues in the form of employee compensation, and these costs grew by 3% in 2018, the fastest pace during the current economic expansion, which began in June 2009, Goldman Sachs reported this week. Goldman believes that stocks with lower than average labor costs as a percentage of sales are well-positioned to outperform in this environment.
Five years in the making. That is essentially the time it has taken for the S&P 500 to hit a milestone mark at 3,000 for the first time in its history. The stock gauge first closed at 2,000 on Aug. 26, 2014, according to Dow Jones Market Data.
This morning, US index futures surged after Federal Reserve Chair Jerome Powell’s testimony raised the possibility of a near-term cut in interest rates.
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
SAN JOSE, Calif., July 01, 2019 -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report second quarter 2019 financial results on Wednesday, July.
Wild price swings have swept across the major indexes this holiday season. Explore three high-beta stocks to trade the increased volatility.
The termination of discussion related to Straumann's iTero distribution is a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
shares sank 5.8% to $287.91 Monday after announcing that talks had ended between the medical device company and the Straumann Group over a possible development and distribution agreement. The potential agreement had been discussed in connection with the patent settlement agreement announced by the two companies in March. The San Jose, Calif.-based company said that as part of the settlement, Straumann will pay Align an additional $16 million in lieu of the agreement.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Align Technology...
The termination of the Straumann agreement comes as a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
SAN JOSE, Calif., June 13, 2019 -- Align Technology, Inc. (NASDAQ: ALGN) and Straumann Group today announced that they have terminated discussions regarding a possible.
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. […]
The latest development in Align Technology's (ALGN) iTero arm is expected to be a perfect strategic fit for the company as it will help it further grow its patient base for intraoral scanner.
SAN JOSE, Calif., June 12, 2019 -- Align Technology, Inc. (NASDAQ: ALGN) announced today the availability of the iTero Element Foundation intraoral scanner with restorative.